My thanks to my longtime friend (I avoid the term "old friend" for such a young woman) Kennita Watson for alerting me to this lecture at Stanford on 23 June 2004: "The Artificial Synapse Chip: Towards an Electronic Prosthetic Retina" by Harvey A. Fishman, M.D., Ph.D, Stanford University School of Medicine, the Director of Ophthalmic Tissue Engineering and Chief Ophthalmology Resident in the department of Ophthalmology.
Age-related macular degeneration (AMD) is the most common form of severe and irreversible blindness in the U.S. Our research program consists of a highly interdisciplinary effort between physicians, engineers, and scientists to develop a neural interface that will connect the output from a digital camera to individual retinal cells in patients with AMD, thus bypassing injured cells.
By the way, this sounds like a skillset for the type of research physician I find really interesting:
Posted by Russell Whitaker at May 19, 2004 09:40 AM | TrackBack
Dr. Fishman's area of expertise is translational research that uses a multidisciplinary approach to develop novel therapies for blinding diseases in the eye – in particular, Age-Related Macular Degeneration. His research bridges the gaps between tissue engineering, surface science, nanofabrication, chemistry, neuroscience and retinal transplantation biology in Ophthalmology. His background in new technologies and medical science is diverse including bioMEMS, chip-based microfluidics and confocal and time-lapse microscopy, neuroscience/nerve cell regeneration and macular diseases in Ophthalmology. He has made contributions in the fields of microfluidics, laser-induced fluorescence detection, separation science, and biosensors.